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Tumor growthCancer-associated ﬁbroblasts play a crucial role in accelerating tumor progression, but there is a knowledge gap
regarding the chemotactic signal activated in a tumormicroenvironment. In this study, the expression of type IV
collagen was knocked down using a lentiviral-mediated short hairpin RNA strategy. Although there was no
obvious effect on cell growth in vitro, silencing the Col4-α1 gene decreased the tumorigenicity of B16F10 in
C57BL/6 mice, which was accompanied by a reduction in the inﬁltration of alpha-smooth muscle actin-positive
(α-SMA+)ﬁbroblasts. Silencing the Col4-α1 gene or disrupting integrin engagement by blocking the antibody re-
duced the expression of platelet-derived growth factor A (PDGF-A), a potent chemotactic factor for ﬁbroblasts.
Furthermore, ectopic expression of the autoclustering integrin mutant signiﬁcantly stimulated PDGF-A expres-
sion in murine B16F10 and human U118MG and Huh7 cells. PDGF-A-speciﬁc sh-RNA and neutralizing anti-
PDGF-A antibody effectively inhibited the transwell migration of ﬁbroblasts. Adding recombinant PDGF-A back
to shCol cell-conditioned media restored the ﬁbroblast-attraction ability indicating that PDGF-A is a major che-
motactic factor for ﬁbroblasts in the current study model. The integrin-associated PDGF-A production correlated
with the activation of Src and ERK. High type IV collagen staining intensity colocalized with elevated PDGF-A ex-
pression was observed in tumor tissues obtained from hepatoma and glioma patients. The integrin signal path-
way was activated by collagen engagement through Src and ERK, leading to enhanced PDGF-A production,
which serves as a key regulator of ﬁbroblast recruitment.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Solid tumors are surrounded by distinctive basement membrane-
like structural barriers that physically separate them from other tissue
compartments [1,2]. Extracellular matrix (ECM) molecules constituting
the basement membrane contain laminins, collagen type IV, nidogens,
and heparan sulfate proteoglycans [1,3,4]. Many tumors exhibit aber-
rant deposition of ECM as compared with that of their normal counter-
parts [5,6]. In particular, a positive correlation of type IV collagen
expression with tumor malignancy has been documented in severalgy and Immunology, College of
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u.edu.tw (B.-C. Yang).clinical studies. Type IV collagen is a major component of the complex
basement membrane zone, where it has an important molecular ﬁltra-
tion function. This microenvironmental change is considered to be im-
portant for tumor progression and metastasis. For instance, distinct
organizational and distribution patterns of type IV collagen around tu-
mors have been associated with tumor progression in melanoma and
colorectal carcinoma [7,8].
Accompanied with atypical matrix composition, various types of
cells, including ﬁbroblast, vascular, glial, smooth muscle, epithelial, fat,
and immune cells, inﬁltrate into tumor stroma, a process which further
contributes to the altered tissue architecture of tumor tissue [9]. Among
these cells, cancer-associated ﬁbroblasts play a crucial role in accelerat-
ing tumor progression through multiple mechanisms for cell viability,
immune evasion, and epithelial–mesenchymal transition [10–12].
Despite a positive correlation of excessive type IV collagen deposition
and altered stromal inﬁltration, there is a knowledge gap regarding
the signal transduction pathways initiated by collagen deposition as
they relate to the altered stromal inﬁltration.
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collagen matrices exhibit elevated activation of non-receptor focal
adhesion kinase and small GTP binding protein, leading to increased
cell proliferation and invasiveness [13]. Speciﬁcally, the signal initiated
by integrin engagement with collagen confers high invasiveness of
human pancreatic cells through extracellular signal-regulated kinase
(ERK) activation [14]. Rac and ERK pathways have been shown to be
required for ﬁbroblast activation and migration [15,16]. These ﬁndings
raise the possibility that aberrant collagen-associated signaling is
involved in cancer-associated ﬁbroblast recruitment. In this study, the
molecular mechanism linking collagen deposition and ﬁbroblast inﬁl-
tration in tumors is elucidated. By knocking down the Col4-α1 gene,
integrin-associated signaling and platelet-derived growth factor A
(PDGF-A) expressions in various tumor cell lines were impaired. In
addition, the knockdown strategy drastically reduced the capacity of
tumor cell lines to recruit myoﬁbroblasts both in vitro and in vivo.
Based on theseﬁndings, amechanism for stromal cell inﬁltration initiated
by the deposition of collagen is proposed.2. Materials and methods
2.1. Antibodies and reagents
Rabbit antibodies (Abs) for type IV collagen and PDGF-A were
obtained from Novus Biologicals LLC (Littleton, CO). Rabbit Abs speciﬁc
for Src, phospho-Src, ERK, and phospho-ERK were obtained from Cell
Signaling Technology (Beverly, MA). Mouse Abs for GAPDH and CD29
were purchased from BD Pharmingen (San Diego, CA). Mouse anti-
human integrin β1-blocking Ab was obtained fromMillipore (Billerica,
MA). Puriﬁed NA/LE hamster anti-rat CD29-blocking Ab was purchased
from BD Pharmingen. Mouse anti-mouse and human α-smoothmuscle
actin (SMA) antibodies were purchased from Sigma-Aldrich (St. Louis,
MO). Recombinant PDGF-A and neutralizing anti-PDGF-A Ab were pur-
chased from Sigma-Aldrich. Growth factor-reduced matrigel was pur-
chased from BD Bioscience (Bedford, MA). Inhibitors for MEK (U0126)
and Src family kinase (PP1) were purchased from Calbiochem (La
Jolla, CA). Puromycin was purchased from Sigma-Aldrich. Short hairpin
(sh) RNA interference pLKO.1-shColIV for type IV-α1 collagen and
pLKO.1-shPDGF-A were obtained from the National RNAi Core Facility
of Taiwan (Taipei, Taiwan). Plasmids encoding β1-integrin wild-type,
constitutively active (G429N), and autoclustering (V737N) variants
were kindly provided by Dr. Valerie M. Weaver (UCSF Helen Diller
Family Comprehensive Cancer Center, USA).Table 1
Quantitative real-time PCR oligonucleotide primers used in this study.
Gene Primer sequences (5′→ 3′) mRNA target
sequence (NCBI)
Human
Col4-α1 Forward primer: ACTCTTTTGTGATGCACACCA NM_001845.4
Reverse primer: AAGCTGTAAGCGTTTGCGTA
PDGF-A Forward primer: CCCTGCCCATTCGGAGGAAGAG XM_005249770.1
Reverse primer: AAGTTGGCGGACGTGGGGTCGA
GAPDH Forward primer: TTCCAGGAGCGAGATCCCT NM_001289746.1
Reverse primer: CACCCATGACGAACATGGG
Mouse
Col4-α1 Forward primer: GCTCTGGCTGTGGAAAATGT XM_006508693.1
Reverse primer: CTTGCATCCCGGGAAATC
PDGF-A Forward primer: CTCTTGGAGATAGACTCCGTAGG XM_006504658.1
Reverse primer: ACTTCTCTTCCTGCGAATGG
GAPDH Forward primer: AAGGTCATCCCAGAGCTGAA NM_001289726.1
Reverse primer: CTGCTTCACCACCTTCTTGA2.2. Cell culture
Mouse melanoma cell line B16F10, mouse ﬁbroblast cell line NIH3T3,
human glioma cell line U118MG, and human fetal lung ﬁbroblast cell line
MRC-5 were obtained from the American Type Culture Collection
(Manassas, VA). Humanhepatocellular carcinoma cell lineHuh-7was ob-
tained from the Japanese Collection of Research Bioresources Cell Bank
(Tokyo, Japan). Cells were cultured in Dulbecco's modiﬁed Eagle's medi-
um (DMEM) medium (Invitrogen, Carlsbad, CA) supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, and 1% antibiotic–
antimycotic. Viable cells were counted using a trypan blue dye exclusion
assay.
Cell growthwasdetermined using theMTT assay. About 2× 103 cells
in 100 μl of mediumwere seeded into wells of a 96-well plate and incu-
bated for the indicated time. At the end of incubation, 10 μl of 5 mg/ml
MTT solutionwas added into eachwell. After incubation for another 4 h,
the purple crystal sediment was dissolved in 150 μl DMSO and read at
540 nm in an ELISA reader. The absorbance valuewas used to represent
the cell number.2.3. Lentivirus production and cell transduction
To knock down the expression of type IV-α1 collagen and PDGF-A,
tumor cells were transduced with lentivirus encoding shRNA for
the Col4-α1 and pdgf-a genes, respectively. The packaging plasmid
(psPAX2) and envelope plasmid (pMD2.G) were kindly provided by
Dr. Y. L. Lin (Centre National de la Recherche Scientiﬁque, France). To
produce lentivirus, 15 μg of the transfer plasmid, 9 μg of the packaging
plasmid (psPAX2), and 6 μg of the envelope plasmid (pMD2.G) were
cotransfected into 293T cells using a calcium phosphate method. After
24 h of transfection, the cells were cultured in 15 ml of fresh serum-
freemedium for another 48 h. Culturemediumwith virionswas collect-
ed, ﬁltered through a 0.45-μm ﬁlter, and further cleaned using centrifu-
gation. For transduction, tumor cells were infected with appropriate
amounts of virus suspension containing polybrene (Sigma-Aldrich) for
16 h. Alternatively, plasmid DNA was directly delivered into the cells
using lipofection at a ratio of 2 μg DNA/5 μ1 LipofectamineTM 2000
(Invitrogen) according to the manufacturer's protocol.
2.4. Quantitative real-time PCR
RNAwas isolated using a High Pure RNA Isolation Kit (RocheMolec-
ular Biochemicals, Mannheim, Germany) and treated with DNase to
eliminate genomic DNA contamination. Quantitative real-time PCR
was conducted using SYBR Green PCR MasterMix according to the
manufacturer's instructions. 50 ng of template cDNA in SYBR® Green
master mixes in total 20 μl volume was used for PCR reaction and run
on a StepOnePlus™ Real-Time PCR System in triplicate (Applied
Biosystems, Foster City, CA, USA). To normalize readings, we used
GAPDH as internal control for each run. The real time PCR conditions
were 95 °C for 15 s, 60 °C for 60 s for 40 cycles. The primers used for am-
pliﬁcation are listed in Table 1. Data was analyzed by StepOne Software
v2.3 (Applied Biosystems).
2.5. Reverse-transcription polymerase chain reaction
Total RNA was reverse-transcribed into cDNA with Oligo(dT)10–18
primers and MMLV reverse transcriptase (Invitrogen). Supplementary
Table S1 summarizes the primer sequences for the target genes used
for the polymerase chain reaction (PCR) in this study. PCR products
were separated by 2% TAE agarose electrophoresis and made visible
by ethidium bromide staining.
2.6. Western blot analysis
Total cell proteins were extracted with a buffer containing 250 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM
Fig. 1. Knocking down of type IV-α1 chain collagen. B16F10 cells were transduced by lentivirus carrying shRNA for the Col4-α1 gene (denoted as shCol cells). The expression of (A) type
IV-α1 collagen transcript and (B) protein levels were detected using RT-PCR and Western blot analysis, respectively. Cell growth was measured by direct cell counting using
(C) hemocytometry and (D) MTT assay. Shown are the averages of three independent experiments.
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containing 500 μM AEBSF, 1 μg/ml aprotinin, 1 μM E-64, 500 μM EDTA,
and 1 μM leupeptin (Calbiochem). Proteins were separated using 8–
12% SDS-PAGE and transferred to a polyvinylidene ﬂuoride membrane.
After being blocked with 5% skimmilk, themembrane was probedwith
the primary antibody that recognized the target proteins followed by
appropriate horseradish peroxidase (HRP)-conjugated secondary anti-
body. The target proteins were made visible with ﬂuorography using
an enhanced chemiluminescence detection kit (Amersham Biosciences,
Piscataway, NJ).
2.7. In vitro chemo-attractive invasion assay
The invasion assay was done using a chemotaxis chamber (8-μm
pores, 6.5-mm diameter) with a matrigel (30 μg/well)-coated polycar-
bonate ﬁlter. NIH3T3 or MRC-5 cells were seeded in the upper well of
each chamber compartment. Tumor-cell-conditioned media serving as
the chemoattractant was loaded into the lower chamber. To visualize
the transmigrated cells, the cells were ﬁxed with 10% formaldehyde
for 10 min and stained with 20% Giemsa stain for 15 min. The cells in
the upper chamber were removed with a cotton swab. Transmigrated
cells were counted under a light microscope.
2.8. In vivo tumor formation
To generate tumor nodules, approximately 5 × 105 B16F10 cells
were subcutaneously injected into C57BL/6 mice (9–12 weeks old).
The tumor volume was calculated as 3.1416 × length × width2/6. The
mice were maintained in ﬁlter-top micro-isolator cages and provided
with sterilewater and food under regulations of the Institutional Animal
Care and Use Committee of National Cheng Kung University. All manip-
ulations of experimental animals were conducted in a laminar-ﬂow
hood using controlled procedures adhering to the UKCCCR Guidelines
for theWelfare of Animals in Experimental Neoplasia tominimize stress
or suffering [17].
2.9. Immunoﬂuorescence staining
Glioma and hepatoma tissues were obtained from the National Core
Facilities of the National Research Program for Genomic Medicine-Tumor Tissue Bank in Southern Taiwan. Tumor tissues were ﬁxed with
3.7% formaldehyde and embedded in parafﬁn. Parafﬁn-embedded
tumor samples were cut into 5-μm-thick sections. Tissue sections
were deparafﬁnized using a standard protocol. Tissue sections were
blocked with 1% BSA to prevent nonspeciﬁc antibody binding. Endoge-
nous peroxidase was quenched with hydrogen peroxide (0.3%) in PBS
for 15min. Hybridizationwas donewith primary antibodies at dilutions
ranging from 1:200 to 1:500 to get optimal stains followed by appropri-
ate secondary antibodies conjugatedwith ﬂuorescence dyes. Tissue sec-
tions were observed under a ﬂuorescence microscope (Olympus CellR
microscope).
2.10. Statistical analysis
Data are expressed as the mean ± standard deviation. The differ-
ences between groups were analyzed using Student's t-test; p b 0.05
was considered signiﬁcant. Data were interpolated with the software
GraphPad Prism 5 (GraphPad Software).
3. Results
3.1. Impaired tumorigenesis of B16F10 cells and reduced myoﬁbroblast
inﬁltration by knocking down Col4-α1 gene
To reduce collagen expression, cells were transfectedwith lentivirus
encoding shRNA speciﬁc for targeting the Col4-α1 gene (denoted as
shCol cells). The reduction of type IV collagen at both transcript and
protein levels in B16F10-derived shCol cells was conﬁrmed by RT-PCR
(Fig. 1A) and Western blot analysis (Fig. 1B), respectively. Silencing
the Col4-α1 gene did not affect the growth of B16F10 cells in vitro
(Fig. 1C, D). However, it signiﬁcantly impaired subcutaneous tumor for-
mation in C57BL/6 mice in terms of both the size and weight of the
tumor nodules (Fig. 2A, B). In addition, histochemical staining of tissue
sections with hematoxylin and eosin shows that the tumor of B16F10-
derived shCol cells had a less compact ﬁber-like network structure
with reduced stromal cell inﬁltration as compared to that of the control
group (Fig. 2C). Most of the inﬁltrating cells in the tumor stroma of the
control groupwere positive forα-SMA. Notably, a substantial reduction
of inﬁltrating ﬁbroblasts was found in tumors derived from B16F10-
derived shCol cells (Fig. 2D).
A) B)
C) H/E stain of tissue section
Control tumor nodule shCol tumor nodule
D) -SMA stain
Control tumor nodule
shCol tumor nodule
Fig. 2.Reduced tumor growth andﬁbroblast inﬁltration of B16F10-derived shCol cells. Approximately 5×105 cellswere subcutaneously inoculated into C57BL/6mice (n=7/group). (A) A
tumor mass appeared approximately 10 days after cell inoculation. The tumor volume was calculated at indicated intervals (*: p b 0.05 compared with control cells). (B) Tumor nodules
were surgically obtained at 13 days post-injection andweighed. (C) Tumor samples were ﬁxedwith 3.7% formaldehyde and embedded in parafﬁn. Five-μm tissue sectionswere prepared,
deparafﬁnized, and stained with hematoxylin and eosin (H/E). (D) Immunoﬂuorescence staining for α-SMA. Cell nuclei were visualized by 4′,6-diamidino-2-phenylindole stain (blue).
Arrows indicate some α-SMA positive cells. Shown are representative images.
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In agreement with the reduction in ﬁbroblast inﬁltration in B16F10-
derived shCol tumors, the conditioned medium of the shCol group wasless effective in attractingNIH3T3 ﬁbroblasts, as compared to that of the
control (Fig. 3A). The B16F10 cells expressed transforming growth fac-
tor beta (TGF-β) and PDGF-A, which are potent ﬁbroblast chemokines
[18,19]. Knocking down the Col4-α1 gene signiﬁcantly reduced the
Fig. 3. Reduction of ﬁbroblast recruitment ability and PDGF-A expression of B16F10-derived shCol cells. The B16F10-derived shCol cells were established as described in Fig. 1.
(A) Fibroblast recruitment assay was done in a 6-well transmigration plate. Conditioned media collected from B16F10-derived control and shCol cells with or without 10 ng/ml PDGF-
A growth factor were used as an attractant and loaded in the lower chamber. NIH3T3 ﬁbroblasts were loaded into the upper chamber. The NIH3T3 cells migrating across the membrane
in this setting at the indicated time durations were ﬁxed, stained with 20% Giemsa stain, and counted. (B) Transcripts of PDGF-A and TGF-β in B16F10 cells were determined by RT-PCR.
(C) Type IV collagen and PDGF-AmRNA expression levels were analyzed by quantitative real time PCR. (D) Type IV collagen and PDGF-A proteinswere detected byWestern blot analysis.
GAPDH served as the loading control. Shown are the averages of three independent experiments. *: p b 0.05 compared with control cells.
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the B16F10-derived shCol cells produced less PDGF-A protein (Fig. 3D).
To verify the role of PDGF-A in ﬁbroblast attraction, the pdgf-a gene in
B16F10 cells was also knocked down (Fig. 4A). B16F10 cells expressing
low levels of PDGF-A had a reduced chemotactic ability to attract
NIH3T3 ﬁbroblasts as compared to the control group (Fig. 4B). Besides,
neutralizing anti-PDGF-A Ab effectively inhibited the transwell migra-
tion of ﬁbroblasts (Fig. 4C).
The expression of PDGF-A in tumor samples of human glioma and
hepatoma patients was conﬁrmed by immunoﬂuorescence staining.
Some tumor cells showed intense type IV collagen stain in the cyto-
plasm. Positive staining for PDGF-Awas found in scattered cells of tissue
areas that had high type IV collagen deposition (Fig. 5A).
The Col4-α1 gene of human glioma cell line U118MG and hepatoma
cell line Huh7 was also knocked down. In parallel with a reduced
expression of type IV collagen, U118MG- and Huh7-derived shCol
cells had decreased PDGF-A expression (Fig. 5B, C). Accordingly, theconditionedmedia of U118MG- and Huh7-derived shCol cells exhibited
a lower ability to attract human MRC-5 ﬁbroblasts. Adding PDGF-A back
to shCol cell-conditionedmedia restored ﬁbroblast chemotaxis (Fig. 5D).
The conditioned media of U118MG and Huh7 parental cells treated with
neutralizing anti-PDGF-A Ab had a lower ability to attract ﬁbroblasts as
compared to that treated with control Ab (Fig. 5E)
3.3. Contribution of integrin signaling to collagen-associated
PDGF-A expression
Integrins are cell surface receptors that interact with ECMmolecules.
In response to ECMengagement, Src and ERK are activated, representing
the main components of integrin-mediated signaling [20]. α1β1 and
α2β1 integrins are the major cell bindingmolecules for type IV collagen
[21]. Knockingdown theCol4-α1 gene severely impaired integrin signal-
ing, as was evident in the decreased Src and ERK phosphorylation of
shCol cells (Fig. 6A). To test whether integrin receptors are involved in
Fig. 4. Impaired ﬁbroblast recruitment by knock-down PDGF-A expression. B16F10 cells were transduced by lentivirus encoding the shRNA for the pdgf-a gene. (A) The expression of
PDGF-A was measured usingWestern blot analysis. (B) Fibroblast recruitment assay was done with the conditions described in Fig. 3. The conditioned media collected from B16F10-de-
rived cells expressing different levels of PDGF-Awere used as attractants and loaded in the lower chamber. (C) Fibroblast recruitment assaywas done using the conditions as described in
Fig. 3. The conditionedmedia collected fromB16F10 parental cells treatedwith 20 μg/ml neutralizing anti-PDGF-AAbwere used as attractants and loaded in the lower chamber. Shownare
the averages of three independent experiments (*: p b 0.05 compared with control group).
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collagen was disrupted using a β1-integrin-blocking antibody. The
expressions of PDGF-A in B16F10, U118MG, and Huh7 cells were signif-
icantly inhibited by β1-integrin-blocking antibody both at RNA and pro-
tein levels. In parallel to a reduction in PDGF-A, β1-integrin blockade
also suppressed the phosphorylation of Src andERK (Fig. 6B). Distinctive
signals generated by different degrees of integrin activation and cluster-
ing may have varied impacts on tumorigenesis [22,23]. To differentiate
the integrin status for PDGF-A production, integrin mutants with
autoactivation or autoclustering ability were ectopically expressed in
B16F10 cells. Although the integrin G429N variant was less effective,
wild-type and autoclustering (V737N) integrin variants triggered pro-
found phosphorylation of ERK and Src and the expression of PDGF-A
(Fig. 6C).3.4. Effect of kinase inhibitors on PDGF-A expression
Knowing that Src and ERK were activated in the present study
model, we set out to assess the causal relationship between these kinase
activities and PDGF-A expression using pharmacological inhibitors.
Inhibition of ERK phosphorylation by U0126 effectively suppressed the
expression of PDGF-A (Fig. 7A). Treatment with PP1 for a short time
period (1 h) reduced the phosphorylation of Src and ERK (Fig. 7B). How-
ever, the phosphorylation of Src and ERK rebounded quickly with
prolonged exposure to PP1 (12-24 h), indicating a compensation mech-
anism for Src kinase. Despite the ﬂuctuation of Src kinase, cells with a
higher phospho-Src status consistently exhibited higher degrees of
phospho-ERK and PDGF-A expression (Fig. 7B).4. Discussion
Fibroblasts constitute themajority of stromal cells within the prima-
ry tumor bed in various types of human carcinomas and contribute to
tumor progression [24]. Selective targeting of cancer-associated ﬁbro-
blasts has recently attracted great interest and could provide novel
strategies for treating cancer [25]. In the present study, we identiﬁed a
collagen-associated signaling mechanism in the tumor environment
for the production of PDGF, which is a major cytokine responsible for
ﬁbroblast recruitment. When the expression of type IV collagen of
B16F10 cells was knocked down using the shRNA strategy, it resulted
in hampered tumor growth in mice. Notably, inﬁltration of α-SMA-
positive ﬁbroblasts, in stromal and tumor areas, was also drastically
reduced, indicating a link between collagen deposition, ﬁbroblast
recruitment, and tumor growth.
PDGF-A and TGF-β aremajor chemokines implicated inﬁbroblast re-
cruitment in several ﬁbrotic diseases, including tumors [26,27]. PDGF
potently promotes myoﬁbroblast proliferation and chemotaxis, while
TGF-β stimulates collagen deposition in ﬁbrogenesis by newly replicated
myoﬁbroblasts [28–30]. Although B16F10 cells expressed both PDGF-A
and TGF-β, only the expression of PDGF-A was altered by knockdown
of the collagen gene. A positive correlation of PDGF-A expression and
the level of type IV collagen was also demonstrable in human tumor
cells. In human glioma and hepatoma tissue samples, tumor ﬁbroblasts
were frequently observed in areas where there was a strong expression
of type IV collagen and PDGF-A. Knockdown of the collagen gene effec-
tively reduced the expression of PDGF-A in U118MG and Huh-7 cells
and also impaired their ability to induce ﬁbroblast migration. We have
further used two strategies to establish a causal relationship between
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speciﬁc sh-RNA and neutralizing anti-PDGF-A antibody effectively
inhibited the transwellmigration ofﬁbroblasts. Second, adding recombi-
nant PDGF-A back to shCol cell-conditioned media restored ﬁbroblast
chemotaxis further indicating that PDGF-A is a major chemotactic factor
for ﬁbroblasts in the current studymodel. This collagen-related signaling
modulated the expression of PDGF-related factors, including PDGF-B,
PDGF-C, and PDGF-D (Supplementary Fig. 1), whichmay also contributeFig. 5. Correlation of type IV-α1 collagen and PDGF-A expression in human cancer cells. (A
deparafﬁnized, and dual-immunoﬂuorescence stained for type IV collagen and PDGF-A with ap
within the tumor section. (B) The U118MG- andHuh7-derived shCol cells were established as de
mined by quantitative real time PCR. (C) Type IV collagen and PDGF-A proteinswere detected byW
was done using human ﬁbroblast MRC-5 cells in the conditions described in Fig. 3. Conditione
10 ng/ml PDGF-A growth factor were used as attractants. (E) The conditioned media collected
PDGF-A Ab or control Ab and then used as attractants and loaded in the lower chamber. Shownto ﬁbroblast recruitment [31–33]. Thus, type IV collagen deposition
creates a ﬁbroblast-favoring microenvironment by stimulating tumor
cells to produce a panel of ﬁbroblast chemoattractants.
The receptors of type IV collagen include α1β1/α2β1 integrins,
DDR1, CD47, and CD44 [34–36]. Among these, β1 integrin is the major
common receptor component for type IV collagen [37,38]. We noted
that tumors produced from B16F10-derived shCol cells have a loose, fri-
able texture at the stroma area (Fig. 2C), indicating altered tissue rigidity) Five-μm parafﬁn-embedded tissue sections of glioma and hepatoma were prepared,
propriate antibodies. Arrows indicate that type IV collagen and PDGF-A were colocalized
scribed in Fig. 1. The transcripts of PDGF-A in U118MG- and Huh7-derived cells were deter-
estern blot analysis. GAPDH served as the loading control. (D) Fibroblast recruitment assay
d media collected from U118MG- and Huh7-derived cells supplemented with or without
from U118MG and Huh7 parental cells were pretreated with 20 μg/ml neutralizing anti-
are the averages of three independent experiments. *: p b 0.05 compared with control cells.
Fig. 5 (continued).
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production has been reported in several cell models under physiological
conditions. For example, the binding of aggretin to α2β1 integrin has
been found to induce PDGF production in vascular smooth muscle
cells [39]. In human platelets, binding of collagen to integrins stimulates
the production of PDGF-A/B via the ERKpathway [40]. Intrinsic activation
of integrin has been observed in tumors in response to high-rigidity mi-
croenvironments, which is a hallmark of solid tumors, partly due to ECM
deposition [41,42]. Our ﬁndings further support that integrin receptors
are candidates for PDGF indication. Indeed, preventing the engagement
of collagen and integrin via a blocking antibody suppressed the phos-
phorylation of Src and ERK and simultaneously reduced the expression
of PDGF-A. By ectopical expression of autoactivation or autoclustering
integrin variants in tumor cells, we conﬁrmed that the signal associated
with integrin clustering is responsible for major Src and ERK activation
and PDGF-A expression. Furthermore, pharmacological inhibition of
ERK effectively reduced the expression of PDGF-A and PDGF isoforms
(Supplementary Fig. 2), indicating that both PDGF-A and PDGF isoform
production may be regulated by the same pathway. Thus, we propose
that collagen/integrin-associated signaling is responsible for the PDGF
production and the expansion of the ﬁbroblast population in the tumor
region that initiates a vicious cycle for elevated tissue stiffness and subse-
quent tissue abnormality (Fig. 8).
Targeting PDGF receptors in the stroma has been found to inhibit
lung cancer growth and bone metastasis, and colon cancer growth andFig. 6. Contribution of integrin signaling to collagen-associated PDGF-A expression. The B1
(A) Protein levels of type IV collagen, pSrc, Src, pERK, ERK, and PDGF-A were determined by W
U118MG, and Huh7 were cultured in fresh medium for 24 h and then treated with 10 μg/ml
using RT-PCR. Protein levels of pSrc, Src, pERK, ERK, and PDGF-Awere determined byWestern b
encoded for β1 integrin wild-type (WT), constitutively active (G429N), and autoclustering (V7
pERK, ERK, and PDGF-A were detected by Western blot analysis.metastasis [43]. Anti-PDGF receptor treatment, however, has limitations
due to its side effects, as PDGF-directed signals play important roles in
development and wound repair.
5. Conclusion
The signaling pathway activated upon collagen/integrin engage-
ment was found to be essential for the production of PDGF, which
plays a prevailing role in ﬁbroblast recruitment in tumor stroma.
Targeting tumor speciﬁc integrin receptors provides an additional strat-
egy for turning off local PDGF production that, in combinationwith anti-
tumor cell treatment, may be of beneﬁt in clinical applications.
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Fig. 7. Suppression of PDGF-A expression by ERK and Src inhibitors. Parental cells were
treated with 25 μM U0126 for 24 h (A) or 10 μM PP1 for the indicated time periods (B).
Protein levels of ERK, pERK, Src, pSrc, and PDGF-Awere determined byWestern blot anal-
ysis. Upper panel of (A) shows the transcripts of PDGF-A of cells treated with U0126
detected by RT-PCR.
Fig. 8. Proposed model for tumor ﬁbroblast inﬁltration initiated by deposition of collagen throu
containing integrin receptors on the tumor cell surface or extracellular space, resulting in abnor
and ERK. In response to the elevated PDGF, ﬁbroblasts are recruited into the tumor region and
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